F554 in District of Columbia. Pick another state for the same tag.
Against expectation — 2025
District of Columbia cites F554 more often than its own record predicts
Versus expected share1.41×
1.41 times the share F554 takes of citations nationally.
Share of District of Columbia citations0.80%
Of every deficiency written in District of Columbia in 2025, this is the portion that was F554.
District of Columbia0.80%
National0.57%
Share of all citations that were F554.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What District of Columbia surveyors wrote
F554 findings written in District of Columbia, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedMay 5, 2025
Based on observation, record review and resident and staff interview, the Interdisciplinary Team (IDT) failed ensure a resident was safe to self-administer an Albuterol inhaler for one (1) of 1 sampled resident who self-administer medicine. (Resident #46).
The findings included:
Resident #46 was admitted on [DATE] with multiple diagnoses including Pulmonary Chronic Obstructive Disease, Bipolar, Schizophrenia, and Anxiety.
A policy titled, Self-Administering Medications with a review date of 05/24/24 instructed, Residents have the right to self-administer medications if the interdispilinary team has determined that it is clincally appropiate and safe for the resident to do so . …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction